Femara - Breast Cancer Home Page
Femara® letrozole is a prescription medication used to treat breast cancer in postmenopausal women. Specifically, the drug has been licensed to treat postmenopausal women who Have advanced or metastatic spreading breast cancer that is either hormone receptor-positive or hormone receptor-unknown. Letrozole is used in the treatment of breast cancer in women who have experienced menopause. Letrozole belongs to a class of drugs known as nonsteroidal aromatase inhibitors. Letrozole decreases the amount of estrogen in the body. This chemotherapy and cancer drugs article is about Letrozole Femara which was approved by the FDA in 1997 to help treat advanced breast cancer in post-menopausal.
Letrozole Femara® Side Effects & Cancer Treatment CTCA
This drug combination helps women live longer- learn about side effects, package insert information, see videos Ribociclib Kisqali + Letrozole Femara Letrozole Femara is a drug. Breast cancer is detected via mammograms, breast self-examination BSE, biopsy, and specialized testing on breast cancer tissue. Oct 08, 2003 The drug Femara may cut the risk of breast cancer recurrence nearly in half among postmenopausal women with hormone-dependent breast cancers.
Letrozole Side Effects, Dosages, Treatment, Interactions.
Letrozole is a prescription drug is used to treat certain types of breast cancer such as hormone-receptor-positive breast cancer in women after menopause. Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Breast Cancer Discussion Forums - Access the shared knowledge of thousands of people affected by breast cancer